Treating Advanced Head and Neck Cancer When Cisplatin Is Not an Option

被引:4
作者
Jhawar, Sachin R. [1 ,2 ]
Bonomi, Marcelo [3 ,4 ]
Harari, Paul M. [5 ]
机构
[1] Ohio State Univ, Ctr Comprehens Canc, Dept Radiat Oncol, Arthur G James Canc Hosp, 460 West 10th Ave, Columbus, OH 43210 USA
[2] Ohio State Univ, Solove Res Inst, Ctr Comprehens Canc, 460 West 10th Ave, Columbus, OH 43210 USA
[3] Ohio State Univ, Ctr Comprehens Canc, Arthur G James Canc Hosp, Dept Med Oncol, Columbus, OH 43210 USA
[4] Ohio State Univ, Ctr Comprehens Canc, Arthur G James Canc Hosp, Solove Res Inst, Columbus, OH 43210 USA
[5] Univ Wisconsin, Dept Human Oncol, Sch Med & Publ Hlth, Madison, WI USA
关键词
SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; RADIATION-THERAPY; CHEMOTHERAPY; RADIOTHERAPY; CETUXIMAB; CHEMORADIOTHERAPY; FRACTIONATION;
D O I
10.1200/JCO.20.02720
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors' suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in Journal of Clinical Oncology, to patients seen in their own clinical practice.
引用
收藏
页码:7 / 12
页数:6
相关论文
共 50 条
[31]   Chemo-immunotherapy and radiation in locally advanced head and neck cancer: Where do we stand? [J].
Belgioia, L. ;
Becherini, C. ;
Bacigalupo, A. ;
Bonomo, P. .
ORAL ONCOLOGY, 2022, 127
[32]   Patients with head and neck cancer unfit for cisplatin-what next? [J].
Kiyota, Naomi .
LANCET ONCOLOGY, 2024, 25 (12) :1513-1514
[33]   Definitive Altered Fractionation Radiotherapy and Concomitant Weekly Cisplatin for Locally Advanced Head and Neck Cancer [J].
Boulmay, Brian C. ;
Chera, Bhishamjit S. ;
Morris, Christopher G. ;
Kirwan, Jessica ;
Riggs, Charles E. ;
Lawson, Michael ;
Mendenhall, William M. .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (05) :488-491
[34]   SYNCHRONOUS RADIOTHERAPY AND CHEMOTHERAPY WITH CISPLATIN IN THE MANAGEMENT OF LOCALLY ADVANCED OR RECURRENT HEAD AND NECK-CANCER [J].
GASPARINI, G ;
RECHER, GF ;
TESTOLIN, A ;
DALFIOR, S ;
PANIZZONI, GA ;
CRISTOFERI, V ;
SQUAQUARA, R ;
POZZA, F .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1992, 15 (03) :242-249
[35]   Toxicity of Induction Chemotherapy with Docetaxel, Cisplatin and 5-Fluorouracil for Advanced Head and Neck Cancer [J].
Billan, Salem ;
Kaidar-Person, Orit ;
Atrash, Fadi ;
Doweck, Ilana ;
Haim, Nissim ;
Kuten, Abraham ;
Ronen, Ohad .
ISRAEL MEDICAL ASSOCIATION JOURNAL, 2013, 15 (05) :231-235
[36]   COMPREHENSIVE IMRT PLUS WEEKLY CISPLATIN FOR ADVANCED HEAD AND NECK CANCER: THE UNIVERSITY OF WISCONSIN EXPERIENCE [J].
Traynor, Anne M. ;
Richards, Gregory M. ;
Hartig, Gregory K. ;
Khuntia, Deepak ;
Cleary, James F. ;
Wiederholt, Peggy A. ;
Bentzen, Soren M. ;
Harari, Paul M. .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2010, 32 (05) :599-606
[37]   Current issues in combined modality therapy in locally advanced head and neck cancer [J].
Cmelak, Anthony J. .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 84 (02) :261-273
[38]   Safety and efficacy of concurrent carboplatin plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin [J].
Hamauchi, Satoshi ;
Yokota, Tomoya ;
Onozawa, Yusuke ;
Ogawa, Hirofumi ;
Onoe, Tsuyoshi ;
Kamijo, Tomoyuki ;
Iida, Yoshiyuki ;
Nishimura, Tetsuo ;
Onitsuka, Tetsuro ;
Yasui, Hirofumi .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (12) :1116-1121
[39]   Concurrent hyperfractionated accelerated radiotherapy with 5-FU and once weekly cisplatin in locally advanced head and neck cancer [J].
Budach, V. ;
Becker, E. -T. ;
Boehmer, D. ;
Badakhshi, H. ;
Jahn, U. ;
Wernecke, K. -D. ;
Stromberger, C. .
STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 (03) :250-255
[40]   Induction TPF chemotherapy followed by CRT with fractionated administration of cisplatin in patients with unresectable locally advanced head and neck cancer [J].
Okano, Susumu ;
Enokida, Tomohiro ;
Onoe, Takuma ;
Ota, Yosuke ;
Motegi, Atsushi ;
Zenda, Sadamoto ;
Akimoto, Tetsuo ;
Tahara, Makoto .
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (07) :789-797